心脏再同步化治疗在心力衰竭中的研究进展  

Cardiac Resynchronization Therapy in Heart Failure

作　　者：黄晓华 唐名扬 欧登科 李霜 郎明健 张登洪 HUANG Xiaohua;TANG Mingyang;OU Dengke;LI Shuang;LANG Mingjian;ZHANG Denghong(School of Medical and Life Sciences,Chengdu University of Traditional Chinese Medicine,Chengdu 610075,Sichuan,China;Department of Cardiovascular Medicine,Chengdu Fifth People’s Hospital Affiliated to Chengdu University of Traditional Chinese Medicine,Chengdu 611130,Sichuan,China;Department of Cardiovascular Medicine,The General Hospital of Western Theater Command,Chengdu 610083,Sichuan,China)

机构地区：[1]成都中医药大学医学与生命科学学院,四川成都610075 [2]成都中医药大学附属第五人民医院心内科,四川成都611130 [3]西部战区总医院心内科,四川成都610083

出　　处：《心血管病学进展》2022年第7期645-648,656,共5页Advances in Cardiovascular Diseases

基　　金：国家自然科学基金(81800338)。

摘　　要：心脏再同步化治疗是通过为心力衰竭和传导异常的患者提供更多的心肌起搏来改善心脏功能。基于双心室起搏的心脏再同步化治疗是目前不可或缺的治疗手段,但临床中有30%~40%的心力衰竭患者对常规双心室起搏无反应。因此,包括希氏束起搏和左束支区域起搏等更接近生理性的心脏再同步化治疗应运而生,此外,单纯左心室起搏和多点起搏技术等也是未来心脏再同步化治疗的发展方向。现综述心脏再同步化治疗在心力衰竭治疗方面的现状和最新进展,并对其未来的发展前景进行展望。Cardiac resynchronization therapy(CRT)aims to improve cardiac function by providing more cardiac pacing for patients with heart failure and conduction abnormalities.CRT based on biventricular pacing is an invaluable intervention currently used in heart failure patients.However,30%~40%of patients with heart failure have no response to conventional biventricular pacing.Therefore,CRT,including His bundle pacing and left bundle branch regional pacing,came into being.In addition,simple left ventricular pacing and multipoint pacing technology are also the development direction of CRT in the future.This article reviews the current situation and latest progress in CRT,and highlights future prospects in the development of CRT.

关 键 词：心脏再同步化治疗 希氏束起搏 左束支区域起搏 左心室起搏 左心室多点起搏 

分 类 号：R541.6[医药卫生—心血管疾病]